Stolen insulin vials still on the market, FDA warns

ROCKVILLE, Md. Stolen vials of a brand of long-acting insulin may be on the market, the Food and Drug Administration has warned.

The FDA issued a statement Wednesday warning consumers that stolen vials of Novo Nordisk’s Levemir (insulin detemir [rDNA origin]) were not stored or handled properly and may be dangerous for people to use, and that it had received reports of harmful side effects in patients who had used them.

Novo Nordisk warned in June that some of the 129,000 vials of Levemir stolen from a facility in North Carolina had turned up at a hospital in Houston. The vials came from lots numbered XZF0036, XZF0037 and XZF0038.